Access Zymergen Stock and Financial Details

Q: Can you buy Zymergen stock?

You can no longer buy Zymergenstock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.

Zymergen stock FAQs

Company	Sector	IPO Date	IPO Price/Share	Price/Share as of 10/18/22	Since IPO
Zymergen	Healthcare	4/22/2021	$31	$2.43	-92.2%

Round Date	Series	Amount Raised	Post Money Valuation	Price/Share	Lead Investors	Since IPO
9/20	D	$300.0M	$1.7B	$22.33	SoftBank, Baillie Gifford, Baron Funds, DCVC Bio, Perceptive Adivsors, True Ventures	-89.1%
12/18	C	$434.5M	$1.0B	$17.00	SoftBank, Data Collective, Innovation Endeavors, Draper Fisher Jurvetson Management, Two Sigma Ventures, Goldman Sachs (GSAM Credit Alternatives), Hanwha Asset Management	-85.7%
10/16	B	$142.3M	$455.0M	$10.11	SoftBank, Data Collective, True Ventures, AME Cloud Ventures, Draper Fisher Jurvetson, Innovation Endeavors, Obvious Ventures, Two Sigma Ventures, ICONIQ Capital, Prelude Ventures, Tao Capital Partners	-76.0%
6/15	A	$36.5M	$89.5M	$4.99	The Data Collective, ushan Ventures, AME Cloud Ventures, Draper Fisher Jurvetson, HVF, Innovation Endeavors, Obvious Ventures, True Ventures, Two Sigma Ventures	-51.3%
6/15	A-1	$6.6M	$75.7M	$0.76	The Data Collective, ushan Ventures, AME Cloud Ventures, Draper Fisher Jurvetson, HVF, Innovation Endeavors, Obvious Ventures, True Ventures, Two Sigma Ventures	219.7%

Can you buy Zymergen stock?

You can no longer buy Zymergen stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.

How to buy Zymergen stock?

To invest in a private company like Zymergen through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Zymergen stock?

You can no longer sell stock of Zymergen on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.

How to sell Zymergen stock?

If you hold private company shares of Zymergen - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your Zymergen stock on our platform.
Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

Is Zymergen a public company?

No, Zymergen is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Zymergen’s stock ticker symbol?

The ticker symbol of Zymergen is ZY.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Team

Management Team

Zach Serber

Chief Science Officer and Founder

Jack Gold

Chief Marketing Officer

Mina Kim

Chief Legal Officer

Jed Dean

VP of Operations and Engineering

Aaron Kimball

Chief Technical Officer

Richard Pieters

President, Products

Joshua Hoffman

Chief Executive Officer

Judy Gilbert

Chief People Officer

Enakshi Singh

VP of Finance

Board Members

Steven Chu

Stanford University

Deep Nishar

Soft Group International

Rohit Sharma

True Ventures

Jay T. Flatley

Illumina Inc

Matt Ocko

DCVC

Joshua Hoffman

Jed Dean

Sandra E. Peterson

Clayton, Dubilier & Rice, LLC

Forbes 04/01/2022

Ginkgo Buys Embattled Biotech Firm Zymergen For $300 Million

Ginkgo Bioworks acquired biotechnology firm Zymergen, the synthetic biology companies announced Monday morning, marking the final act in Zymergen’s dramatic and brisk fall from grace.

Globe Newswire 10/03/2021

ZYMERGEN DEADLINE ALERT: Faruqi & Faruqi LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Zymergen To Contact Him Directly To Discuss Their Options

NEW YORK, Oct. 03, 2021 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against...

Globe Newswire 09/18/2021

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Zymergen (ZY) Investors of Securities Class Action, Encourages Investors with Losses to Contact Firm’s Attorneys Now

SAN FRANCISCO, Sept. 18, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Zymergen Inc. (NASDAQ: ZY) investors with significant losses to submit your losses...

Globe Newswire 08/23/2021

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Zymergen Inc. (ZY)

LOS ANGELES, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming October 4, 2021 deadline to file...

Zymergen Stock

Register To Buy and Sell Private Company Shares